Proactol is a 100% natural diet pill, clincally proven to help dieters lose weight without side effects. Proactol stops users from absorbing up to 28% of their fat intake from food.





ProShape RX taken which every meal helps dieters lose weight quickly. ProShape RX decreases food cravings, helps prevent fat storage and may also help increase energy levels.





Zotrim, taken 15 minutes before meals, will help dieters eat less. Zotrim will also decrease in-between meal cravings and may also help increase energy levels and boost metabolism.




Bethin is a weight loss compound that was chemically created to provide individuals suffering with obesity with weight loss support. Bethin, which is also labeled under an array of pseudonyms and alternate names, serves to boost dieters’ weight loss results but interfering with hunger receptors in the brain. With this process, dieters consuming Bethin should be able to comfortably limit their food intake while reducing their body fat.
Bethin is most popularly known under the name “Rimonabant.” Rimonabant was created primarily as the active ingredient in a prescription only weight loss product called Acomplia. Acomplia with Rimonabant / Bethin was introduced for prescription use in Europe in the summer of 2006, and has not yet been approved for use in the United States.
To provide individuals who are clinically obese with weight loss support, Bethin selectively blocks various CB1 receptors in the brain. As these receptors are responsible for hunger, food cravings, and the desire to eat / overeat, experts assert that Bethin can effectively reduce a consumer’s discomfort with dieting and weight loss. Adding to this support, Acomplia has also reportedly been shown to help reduce addictive cravings, as especially seen in helping reduce a smoker’s desires / addiction to nicotine and tobacco.
With this benefit, some dietary experts argue that Acomplia / Bethin can help obese individuals lose weight while also overcoming any potential addictions to food. According to a 2001 clinical trial of Acomplia / Bethin in mice, researchers discovered that the mice consuming Acomplia were able to reduce their food intake without any notable serious implications or negative side effects.
As Bethin has only been approved for use in Europe, individuals in the United States may have a difficultly in trying to purchase and consume Bethin. Also, as Bethin has been distributed and marketed under an array of pseudonyms, the reports and information on this product and the reasons for its multiple names is very unclear and rather concerning.
While there are extensive articles and sites focused on the evaluation of other pseudonyms for Bethin, such as Rimonabant and Acomplia, this ingredient as labeled under the title of “Bethin” is not widely evaluated or reviewed. As a result, information specifically on “Bethin” is limited, and it does not appear as though consumers can purchase the product under this title online or in any stores.
Information on Acomplia and Rimonabant, although extensive, is often quite negative. Most notably, individuals consuming Acomplia or the alternative drugs under various names have revealed potentially harmful side effects while taking the drug. Among the potential side effects, Bethin / Acomplia may provoke issues such as: